United Therapeutics Corporation (UTHR) stock has gained 95.56% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives UTHR stock a score of 66 out of a possible 100. That rank is mainly influenced by a short-term technical score of 97. UTHR's rank also includes a long-term technical score of 81. The fundamental score for UTHR is 20. In addition to the average rating from Wall Street analysts, UTHR stock has a mean target price of $233.38. This means analysts expect the stock to climb 18.14% over the next 12 months.
Is United Therapeutics Corporation (UTHR) Stock Worth a Buy Monday?
UTHR has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on UTHR!